Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016)
Lantheus Holdings' (LNTH) quarterly Depreciation & Amortization (CF) came in at -$5.4 million in Q4 2016, down 279.82% year-on-year from $3.0 million in Q1 2016, and down 240.55% on a QoQ basis from $3.8 million in Q3 2016.
Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Depreciation & Amortization (CF) data on file, last reported at -$5.4 million in Q4 2016.
- On a quarterly basis, Depreciation & Amortization (CF) fell 279.82% year-over-year to -$5.4 million in Q4 2016; TTM through Sep 2017 was -$5.4 million, a 133.33% decrease from a year earlier, with the FY2016 full-year figure at $800000.0, down 95.93% from the prior year.
- Depreciation & Amortization (CF) for Q4 2016 stood at -$5.4 million, down from $3.8 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for LNTH reached as high as $8.1 million in Q1 2015 and fell as low as -$5.4 million in Q4 2016.
- Historically, Depreciation & Amortization (CF) has averaged $3.5 million across 3 years, with a median of $4.2 million in 2014.
- Across the five-year window, Depreciation & Amortization (CF) surged 112.05% in 2015 and plunged 279.82% in 2016, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $4.2 million in 2014, then declined by 28.77% to $3.0 million in 2015, then plunged by 279.82% to -$5.4 million in 2016.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were -$5.4 million in Q4 2016, $3.8 million in Q3 2016, and $4.8 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -5.40 Mn |
| Dec 31, 2016 | -5.40 Mn |
| Sep 30, 2016 | 3.84 Mn |
| Sep 30, 2016 | 3.84 Mn |
| Jun 30, 2016 | 4.77 Mn |
| Jun 30, 2016 | 4.77 Mn |
| Mar 31, 2016 | 4.59 Mn |
| Mar 31, 2016 | 4.59 Mn |
| Dec 31, 2015 | 3.00 Mn |
| Dec 31, 2015 | 3.00 Mn |
| Sep 30, 2015 | 4.08 Mn |
| Sep 30, 2015 | 4.08 Mn |
| Jun 30, 2015 | 4.45 Mn |
| Jun 30, 2015 | 4.45 Mn |
| Mar 31, 2015 | 8.12 Mn |
| Mar 31, 2015 | 8.12 Mn |
| Dec 31, 2014 | 4.22 Mn |
| Dec 31, 2014 | 4.22 Mn |
| Sep 30, 2014 | 4.93 Mn |
| Sep 30, 2014 | 4.93 Mn |